David A. Roth
2016 - Syros Pharmaceuticals
In 2016, David A. Roth earned a total compensation of $495.3K as Chief Medical Officer at Syros Pharmaceuticals, a 66% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $115,045 |
|---|---|
| Salary | $380,000 |
| Other | $270 |
| Total | $495,315 |
Roth received $380K in salary, accounting for 77% of the total pay in 2016.
Roth also received $115K in non-equity incentive plan and $270 in other compensation.
Rankings
In 2016, David A. Roth's compensation ranked 11,214th out of 14,075 executives tracked by ExecPay. In other words, Roth earned more than 20.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,214 out of 14,075 | 20th |
Division Manufacturing | 4,355 out of 5,486 | 21st |
Major group Chemicals And Allied Products | 1,563 out of 1,900 | 18th |
Industry group Drugs | 1,262 out of 1,543 | 18th |
Industry Pharmaceutical Preparations | 979 out of 1,173 | 17th |
Source: SEC filing on April 25, 2017.
Roth's colleagues
We found three more compensation records of executives who worked with David A. Roth at Syros Pharmaceuticals in 2016.
News
Syros Pharmaceuticals CEO Nancy Simonian's 2022 pay rises 12% to $3.5M
April 21, 2023
Syros Pharmaceuticals CEO Nancy Simonian's 2021 pay jumps 23% to $3.1M
April 21, 2022
Syros Pharmaceuticals CEO Nancy Simonian's 2020 pay falls 30% to $2.5M
April 29, 2021
Syros Pharmaceuticals CEO Nancy Simonian's 2019 pay rises 19% to $3.6M
April 28, 2020
Syros Pharmaceuticals CEO Nancy Simonian's 2018 pay jumps 36% to $3M
April 25, 2019